Qtron Investments LLC Novo Nordisk A S Transaction History

Qtron Investments LLC

  • $716 Million
  • Q3 2024

A detailed history of Qtron Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Qtron Investments LLC holds 42,515 shares of NVO stock, worth $3.71 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
42,515
Previous 43,021 1.18%
Holding current value
$3.71 Million
Previous $6.14 Million 17.56%
% of portfolio
0.71%
Previous 0.9%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $60,249 - $73,582
-506 Reduced 1.18%
42,515 $5.06 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $474,505 - $631,620
4,647 Added 12.11%
43,021 $5.52 Million
Q4 2023

Feb 12, 2024
SELL
$87.78 - $105.45 $41,256 - $49,561
-470 Reduced 1.21%
38,374 $3.97 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $1.77 Million - $3.88 Million
19,422 Added 100.0%
38,844 $3.53 Million
Q2 2023

Aug 10, 2023
SELL
$155.98 - $172.65 $106,846 - $118,265
-685 Reduced 3.41%
19,422 $3.14 Million
Q1 2023

May 11, 2023
SELL
$132.34 - $159.14 $158,013 - $190,013
-1,194 Reduced 5.61%
20,107 $3.2 Million
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $82,142 - $108,399
801 Added 3.91%
21,301 $2.88 Million
Q3 2022

Nov 10, 2022
BUY
$95.28 - $116.93 $221,049 - $271,277
2,320 Added 12.76%
20,500 $2.04 Million
Q2 2022

Aug 10, 2022
SELL
$103.24 - $121.81 $8,259 - $9,744
-80 Reduced 0.44%
18,180 $2.03 Million
Q1 2022

May 05, 2022
SELL
$93.1 - $112.54 $1,582 - $1,913
-17 Reduced 0.09%
18,260 $2.03 Million
Q4 2021

Feb 16, 2022
SELL
$95.88 - $117.08 $212,374 - $259,332
-2,215 Reduced 10.81%
18,277 $2.05 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $579,543 - $731,946
6,865 Added 50.38%
20,492 $1.97 Million
Q2 2021

Aug 11, 2021
BUY
$67.66 - $84.76 $1,014 - $1,271
15 Added 0.11%
13,627 $1.14 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $206,678 - $233,677
3,082 Added 29.27%
13,612 $918,000
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $115,321 - $133,209
1,805 Added 20.69%
10,530 $736,000
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $550,026 - $606,419
-8,636 Reduced 49.74%
8,725 $606,000
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $148,164 - $171,956
-2,531 Reduced 12.72%
17,361 $1.14 Million
Q1 2020

May 14, 2020
BUY
$49.46 - $64.78 $192,894 - $252,642
3,900 Added 24.39%
19,892 $1.2 Million
Q4 2019

Feb 12, 2020
BUY
$49.86 - $58.26 $359,191 - $419,705
7,204 Added 81.98%
15,992 $925,000
Q2 2019

Aug 13, 2019
BUY
$46.79 - $52.47 $204,706 - $229,556
4,375 Added 99.14%
8,788 $449,000
Q1 2019

May 13, 2019
BUY
$46.36 - $52.63 $204,586 - $232,256
4,413 New
4,413 $231,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Qtron Investments LLC Portfolio

Follow Qtron Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qtron Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email